Cyclerion Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $194 | $0 | $0 | $0 |
Gross Profit | 194 | |||
EBITDA | -1,128 | -1,384 | -1,542 | -1,694 |
EBIT | -1,585 | -1,737 | ||
Net Income | -723 | -1,322 | -1,542 | -1,694 |
Net Change In Cash | 194 | 0 | 0 | 0 |
Free Cash Flow | -1,716 | -1,106 | -1,871 | -1,541 |
Cash | 2,872 | 4,588 | 5,696 | 7,571 |
Basic Shares | 2,526 | 2,510 | 2,494 | 2,474 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $297 | $3,320 | $2,296 |
Gross Profit | 232 | 2,848 | 2,296 | |
EBITDA | -12,593 | -18,181 | -55,195 | -81,265 |
EBIT | -9,647 | -18,246 | -55,667 | -83,562 |
Net Income | -21,015 | -43,784 | -51,663 | -72,670 |
Net Change In Cash | 0 | 297 | 3,320 | 2,296 |
Cost of Revenue | -44,382 | |||
Free Cash Flow | -21,245 | -40,611 | -36,524 | -74,014 |
Cash | 7,571 | 13,382 | 53,961 | 54,395 |
Basic Shares | 2,338 | 2,173 | 1,957 | 1,520 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-06-30 | -$0.52 |
2024-03-31 | -$0.61 |
2023-12-31 | -$0.68 |
